B. Riley Boosts Rigel Pharmaceuticals (NASDAQ:RIGL) Price Target to $24.00
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) had its target price boosted by equities researchers at B. Riley from $20.00 to $24.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the biotechnology company’s stock. B. Riley’s price target would indicate a potential upside of 21.83% from […]
